Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Return on Capital Employed (2016 - 2025)

Medifast (MED) has disclosed Return on Capital Employed for 14 consecutive years, with 0.07% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed fell 8.0% year-over-year to 0.07%, compared with a TTM value of 0.07% through Dec 2025, down 8.0%, and an annual FY2025 reading of 0.06%, down 8.0% over the prior year.
  • Return on Capital Employed was 0.07% for Q4 2025 at Medifast, down from 0.03% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 1.11% in Q3 2022 and bottomed at 0.07% in Q4 2025.
  • Average Return on Capital Employed over 5 years is 0.59%, with a median of 0.78% recorded in 2023.
  • The sharpest move saw Return on Capital Employed rose 27bps in 2021, then crashed -69bps in 2024.
  • Year by year, Return on Capital Employed stood at 1.01% in 2021, then rose by 2bps to 1.02% in 2022, then plummeted by -45bps to 0.57% in 2023, then crashed by -98bps to 0.01% in 2024, then plummeted by -613bps to 0.07% in 2025.
  • Business Quant data shows Return on Capital Employed for MED at 0.07% in Q4 2025, 0.03% in Q3 2025, and 0.0% in Q2 2025.